Zhengye Biotechnology Holding (ZYBT) Buildings (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Buildings for 3 consecutive years, with $22.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Buildings rose 3.79% year-over-year to $22.1 million in Q4 2025; TTM through Dec 2025 was $22.1 million, a 3.79% increase from a year earlier, with the FY2025 full-year figure at $22.4 million, up 6.97% from the prior year.
• Buildings was $22.1 million for Q4 2025 at Zhengye Biotechnology Holding, up from $21.3 million in the prior quarter.
• Over five years, Buildings peaked at $22.1 million in Q4 2025 and troughed at $21.1 million in Q4 2023.
• A 3-year average of $21.5 million and a median of $21.3 million in 2024 frame the typical range for Buildings.
• Across the five-year window, Buildings gained 1.0% in 2024 and rose 3.79% in 2025, its largest moves.
• Over 3 years, Buildings stood at $21.1 million in 2023, then advanced by 1.0% to $21.3 million in 2024, then climbed by 3.79% to $22.1 million in 2025.
• The last three Buildings figures came in at $22.1 million (Q4 2025), $21.3 million (Q4 2024), and $21.1 million (Q4 2023), per Business Quant data.